Takeda Pharmaceutical Co. and Eli Lilly & Co. were ordered to pay a combined $9 billion in punitive damages after a federal court jury found they hid the cancer risks of their Actos diabetes medicine in the first U.S. trial of its kind.
Bloomberg Law Weekend Edition: Best of the Week (Audio)
Bloomberg Law Brief: Kelly Discusses $9 Billion Award (Audio)
Bloomberg Law: Kelly Discusses $9 Billion Award (Audio)
Lechleiter Says R&D Is Company's `Lifeblood'